resveratrol has been researched along with ethoxyresorufin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, TK; Ko, HH; Lee, WB | 1 |
Chang, TK; Chen, J; Lee, WB | 1 |
Braeuning, A; Buckler, F; Köhle, C; Münzel, PA; Schmiechen, A; Schmohl, S; Schreiber, TD; Schwarz, M | 1 |
3 other study(ies) available for resveratrol and ethoxyresorufin
Article | Year |
---|---|
Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1.
Topics: Anticarcinogenic Agents; Aryl Hydrocarbon Hydroxylases; Catalysis; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Humans; Oxazines; Resveratrol; RNA, Messenger; Stilbenes; Tumor Cells, Cultured | 2000 |
Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Topics: Aryl Hydrocarbon Hydroxylases; Binding, Competitive; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; NADP; Oxazines; Recombinant Proteins; Resveratrol; Stilbenes; Substrate Specificity | 2001 |
Regulation of CYP1A1 gene expression by the antioxidant tert-butylhydroquinone.
Topics: Antioxidants; Aryl Hydrocarbon Receptor Nuclear Translocator; Caco-2 Cells; Cell Line; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Hydroquinones; Mutation; Oxazines; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; Resveratrol; RNA, Messenger; Stilbenes; Transfection | 2006 |